GlassScriptPhysician profile
Kalpesh Ganatra
NPI 1700878980
$11,450.57
in general payments reported to CMS, 2019-2025
19 companies · $257 in 2025
The $257 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $6,179 · 2021: $3,082 · 2022: $1,436 · 2023: $121 · 2024: $229 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $607.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $7,948.57 | 2019-2025 | Nucala |
| Ethicon INC. | $1,562.19 | 2022-2025 | Monarch Platform |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,300.00 | 2020 | |
| United Therapeutics Corporation | $210.39 | 2024-2025 | |
| Grifols USA, LLC | $51.15 | 2022-2025 | Prolastin-C Liquid |
| Genentech USA, INC. | $39.95 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $38.83 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $35.37 | 2021-2024 | Tezspire |
| Philips North America LLC | $30.68 | 2025 | Vest Therapy Und |
| Amgen INC. | $30.62 | 2025 | Tezspire |
| Inspire Medical Systems, INC. | $28.86 | 2025 | Inspire |
| Genzyme Corporation | $27.80 | 2020-2025 | |
| Pfizer INC. | $27.53 | 2025 | |
| Vapotherm INC | $27.24 | 2019 | |
| Olympus America INC. | $23.69 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $18.24 | 2023 | Sunosi |
| Regeneron Healthcare Solutions, INC. | $17.71 | 2024 | Dupixent |
| Insmed, INC. | $16.24 | 2020 | |
| Abbvie INC. | $15.51 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kalpesh Ganatra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.